YOLFTbeta
Icecure Medical

Icecure Medical

ICCM · NASDAQ · Healthcare / Medical Devices

0.73USD+0.03 (+4.21%)

Price History

Full chart

Market Stats

Previous Close0.7005
Open0.6833
Day Range0.6763 – 0.7999
52-Week Range1.65 – 42.00
Volume22.77K
Market Cap8.02M
P/E (TTM)0.00
Forward P/E0.00
EPS-6.78
Dividend Yield0.00%
Beta0.45
50-Day Avg2.66
200-Day Avg10.46

About

IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MSense, a multi probe system for the treatment of multiple and larger tumors. The company serves hospitals, interventional radiological centers, ambulatory centers, and private clinics. IceCure Medical Ltd was incorporated in 2006 and is headquartered in Caesarea, Israel.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Eyal Shamir
  • Employees67
  • Headquarters7 Ha?Eshel St., Caesarea, Israel, 3079504, USA
  • Websitehttps://www.icecure-medical.com

Leadership

  • Mr. Eyal ShamirCEO & Director · b. 1961
  • Mr. Shay LevavChief Operating Officer · b. 1978
  • Ms. Tlalit Bussi Tel-TzureVice President of Business Development & Global Marketing · b. 1971
  • Mr. Shad GoodVice President of Sales for North America · b. 1978
  • Mr. Meir PelegChief Financial Officer · b. 1976
  • Ms. Merav Nir DotanVice President of Human Resources · b. 1969
  • Ms. Galit MalikVice President of Operations & Service · b. 1973

Financials

Income Statement

Currency: USD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue354.63K1.07M762.87K625.49K689.38K1.07M1.66M3.87M4.14M3.08M3.23M3.29M3.38M
Growth (%)-+201.32%-28.61%-18.01%+10.21%+55.49%+54.64%+133.35%+6.98%-25.45%+4.67%+1.92%+2.67%
Cost of Revenue453.98K692.10K486.21K403.99K514.44K623.17K1.08M1.42M1.94M1.64M1.93M1.84M2.15M
Gross Profit-99.35K376.48K276.66K221.49K174.93K448.73K576.41K2.44M2.19M1.45M1.30M1.45M1.23M
Gross Margin-28.02%35.23%36.27%35.41%25.38%41.86%34.77%63.19%53.04%46.84%40.26%44.09%36.28%
Operating Expense3.65M4.47M3.81M3.33M2.84M3.62M5.19M6.59M11.92M18.18M16.88M17.15M16.32M
Operating Income-3.75M-4.10M-3.53M-3.10M-2.66M-3.17M-4.61M-4.14M-9.72M-16.74M-15.58M-15.70M-15.09M
Operating Margin-1058.06%-383.27%-462.59%-496.18%-386.56%-295.76%-278.03%-107.08%-234.99%-542.59%-482.38%-476.94%-446.70%
EBITDA-3.95M-3.98M-3.69M-3.03M-2.75M-3.42M-4.60M-4.08M-9.55M-16.50M-15.25M-15.36M-14.80M
EBITDA Margin-1113.28%-372.70%-483.55%-485.04%-398.96%-319.25%-277.25%-105.46%-230.86%-534.85%-472.38%-466.85%-437.97%
Net Income-4.57M-4.71M-3.75M-3.27M-2.88M-3.53M-4.76M-3.73M-9.89M-16.98M-14.65M-15.32M-15.06M
Net Income Margin-1289.96%-441.14%-491.81%-522.82%-417.15%-329.70%-287.18%-96.43%-239.13%-550.34%-453.76%-465.45%-445.61%
R&D846.52K1.01M980.87K1.66M1.50M1.94M2.85M3.81M5.88M9.12M8.27M7.10M7.43M
R&D as % of Total Revenue238.70%94.18%128.58%266.04%217.32%181.08%171.78%98.47%142.03%295.72%256.21%215.62%219.98%
Interest Expense454.08K639.97K198.53K154.94K61.16K73.15K22.81K38.67K171.00K239.00K---
Interest Expense % of Total Revenue128.04%59.89%26.02%24.77%8.87%6.82%1.38%1.00%4.13%7.75%---

Balance Sheet

Currency: USD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-3.31M5.05M3.31M1.93M5.25M7.32M10.24M32.28M30.19M16.41M12.58M13.89M
Total Liabilities-1.46M1.20M1.21M2.19M1.89M4.69M4.59M5.32M4.77M4.25M5.67M4.84M
Total Equity-1.84M3.85M2.10M-256.93K3.37M2.63M5.65M26.96M25.42M12.16M6.90M9.05M
Cash-2.60M4.52M2.82M1.46M4.19M5.78M3.50M25.62M23.66M10.53M7.56M8.90M
Total Debt----936.24K-245.18K332.00K909.00K597.00K599.00K459.00K217.00K
Net Debt--2.60M-4.52M-2.82M-521.06K-4.19M-5.53M-3.17M-24.71M-23.06M-9.93M-7.11M-8.68M

Cash Flow

Currency: USD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-3.47M-3.39M-3.35M-3.13M-2.62M-3.06M-1.74M-3.69M-12.61M-14.29M-12.52M-12.56M-14.57M
Investing Cash Flow-57.72K-34.16K-6.15K-22.88K-8.63K-64.26K-102.23K-4.67M3.79M-891.00K-713.00K446.00K-36.00K
Financing Cash Flow7.83M920.66K5.35M1.40M1.05M5.98M3.06M5.86M30.89M13.58M83.00K9.19M15.83M
Capital Expenditure85.86K34.41K6.15K22.88K8.63K64.26K102.23K223.00K533.00K891.00K480.00K71.00K36.00K
Free Cash Flow-3.56M-3.42M-3.36M-3.15M-2.63M-3.13M-1.84M-3.91M-13.14M-15.18M-13.00M-12.63M-14.61M
FCF to OCF102.47%101.02%100.18%100.73%100.33%102.10%105.87%106.04%104.23%106.23%103.83%100.57%100.25%

Earnings

Report DateDec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Apr 12, 2021Sep 23, 2021May 18, 2022Aug 15, 2022Dec 5, 2022Mar 29, 2023May 22, 2023Aug 14, 2023Nov 15, 2023Feb 20, 2024May 28, 2024Aug 20, 2024Nov 26, 2024Mar 27, 2025May 28, 2025Aug 13, 2025Nov 19, 2025Mar 17, 2026Jun 3, 2026Aug 12, 2026Nov 18, 2026
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.12-3.60-3.45-0.10-2.80-2.60-2.70-0.08-2.40-2.10-2.25-0.08-2.40-1.95-1.65-1.20-0.05-1.37-0.83
EPS Actual-1.69-4.45-4.49-4.60-4.80-3.35-3.37-1.69-1.04-1.50-1.16-1.16-0.80-0.75-0.31-0.25-0.19-0.34-0.19-0.13-0.12-0.11-0.12-0.11-0.09-0.09-0.08-0.09-0.09-0.08-0.08-0.05-0.05-0.09-0.07-0.08-0.08-0.090.12-3.72-3.30-0.11-2.40-2.64-2.61-0.06-2.40-1.80-2.40-0.08-1.80-1.80-1.80-1.80-0.06-3.11-
Surprise--------------------------------------0.00%-3.33%4.35%-10.00%14.29%-1.54%3.33%21.77%0.00%14.29%-6.67%0.00%25.00%7.69%-9.09%-50.00%-16.20%-127.01%-
Timing------------------------------------After-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-market-Pre-marketPre-market

Key Statistics & Ratios

Market Cap8.02M
Enterprise Value-3.46M
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.03
Price / Book0.71
EPS-6.78
Book Value3.47
Revenue (TTM)3.95M
Gross Profit (TTM)1.43M
EBITDA-16.44M
Profit Margin0.00%
Operating Margin-487.76%
Return on Equity-228.31%
Return on Assets-73.88%
Shares Outstanding4.64M
Shares Float2.20M
Beta0.45
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 3 analystsTarget 22.67
  • Strong Buy
    1
  • Buy
    2

Ownership Breakdown

Institutions
12.60%
Insiders
51.49%
Retail / Other
35.91%

Top Institutional Holders

  • Armistice Capital, LLC
    2.71M1.95%
  • Gunderson Capital Management Inc
    20.00K0.43%
  • UBS Group AG
    154.20K0.11%
  • HRT FINANCIAL LLC
    47.60K0.03%
  • Geode Capital Management, LLC
    40.45K0.03%
  • Morgan Stanley - Brokerage Accounts
    17.00K0.01%
  • Foundations Investment Advisors, LLC
    15.00K0.01%
  • Janney Montgomery Scott LLC
    10.17K0.01%
  • JPMorgan Chase & Co
    5.95K0.00%
  • Efficient Wealth Management LLC
    5.85K0.00%
  • BARTLETT & Co WEALTH MANAGEMENT LLC
    80.00%
  • SBI Securities Co Ltd
    90.00%
  • Jane Street Group LLC
    00.00%
  • Warberg Asset Management LLC
    00.00%
  • Hudson Bay Capital Management LP
    00.00%
  • Lloyd Advisory Services, LLC
    00.00%
  • LPL Financial Corp
    00.00%
  • Virtu Financial LLC
    00.00%
  • TWO SIGMA SECURITIES, LLC
    00.00%

Top Fund Holders

  • Fidelity Nasdaq Composite Index
    40.45K0.04%

Stock Splits

  • Jun 4, 20261:30
  • Jul 9, 20251011:992
  • Aug 9, 20211:8
  • Sep 19, 20191291:1289
  • Jan 29, 20181037:947
  • Aug 18, 2016709:590
  • Aug 24, 20151:10